I'm confused by it as well. It makes it seem like an intractable problem, and our experience is that it's not intractable.
There may be some particular uses, and I think that's why blood bags are exempted in the bill, but I have held in my hands the Baxter PVC-free bags, the Baxter PVC-free tubing, the Hospira, formerly Abbott, the two biggest IV manufacturers in the world. Both have now developed PVC-DEHP-free products, and they did it not because we could convince the U.S. government to adopt any stronger language than Health Canada is now suggesting, but rather because we got hospital groups and group purchasing organizations and their shareholders to insist that they develop alternatives.
So we both drove market change by demand from their consumers and by shareholder demands--